ArticleFrontiers in medicine2025
Global research trends and hotspots in erysipelas: a bibliometric analysis from 2000 to 2024.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Two decades of global research on tetanus vaccines and tetanus immunoglobulins: a comprehensive bibliometric analysis and integrative review (2000-2025).Frontiers in cellular and infection microbiology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Erysipelas, an acute bacterial infection affecting the dermis and lymphatic system, poses significant clinical challenges due to recurrence, antibiotic resistance, and diagnostic overlap with other skin infections. Despite growing research in this area, a comprehensive bibliometric analysis is lacking, leaving gaps in understanding the publication trends, key research hotspots, and collaborative networks that shape the field. Methods: This study conducted a bibliometric analysis of erysipelas research from 2000 to 2024 using the Science Citation Index Expanded (SCI-EXPANDED) within the Web of Science Core Collection. English-language articles and reviews were selected, and data were analyzed using VOSviewer, Bibliometrix, and CiteSpace to visualize publication volume, co-authorship networks, geographic distribution, keyword trends, and collaborations. Results: The results indicate a steady growth in erysipelas research from 2000 to 2024, with annual publication volumes increasing from 9 articles in 2000 to 30 articles in 2022, reflecting a significant rise in interest within the field. The United States leads in contributions with 69 publications and 2,739 citations, institutional analysis highlights Radboud University, Karolinska Institute, and others as key contributors in collaboration and citation impact. Keyword co-occurrence analysis identifies major research hotspots, including familial Mediterranean fever, lymphedema therapy, and the management of complex skin infections, with emerging themes like "liposuction" and "skin and soft tissue infections" gaining attention in recent years. Conclusion: This study highlights the growing advancements in erysipelas research, including insights into risk factors, diagnostics, and therapies, while emphasizing the need for continued collaboration and innovation to address challenges like antibiotic resistance, recurrence, and accurate differentiation from similar conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.